Owners of Elizabethtown Hematology Oncology, PLC Agree To Pay Over $3.7 Million to Settle False Billings to Government Health Care Programs
LOUISVILLE, Ky. -Elizabethtown Hematology Oncology, PLC, and its owners have agreed to pay $3,739,325.41 to resolve allegations that they submitted or caused to be submitted false claims for payment to the Medicare, Medicaid, TRICARE - the health care program for Uniformed Service members, retirees and their families worldwide - and the Federal Employee Health Benefit Program (FEHBP) for extending the duration of chemotherapy infusion treatment to patients and inappropriately billing office visits for infusion therapy treatments, announced the Office of Inspector General of the Department of Health and Human Services and David J. Hale, United States Attorney for the Western District of Kentucky.
- Date:June 3, 2014
- Agency:U.S. Attorney
- Criminal and Civil Actions